Rentokil Initial (NYSE:RTO), a global leader in pest control and hygiene services, announced today the appointment of Brian Baldwin to its board as a Non-Executive Director, effective 1 October 2024.
Mr. Baldwin will also join the Nomination Committee and Remuneration Committee upon his appointment.
Brian Baldwin currently serves as the Head of Research at Trian Fund Management, a prominent investment management firm, where he has been a partner since 2013 and a member of the investment team since 2007.
His strategic leadership has significantly influenced many of Trian's investment decisions.
"We are delighted to welcome Brian to the board and look forward to working with him to deliver long-term sustainable value for our shareholders," said, Richard Solomons, Chairman of Rentokil Initial.
The appointment marks a strategic step in bolstering Rentokil Initial’s leadership team as the company pursues substantial growth opportunities in the global pest control market, significantly aided by the recent acquisition of Terminix.